☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
gsk
GSK and CureVac Report Restructuring of their Partnership
July 3, 2024
GSK Reports the Japanese MHLW’s Approval of Omjjara (momelotinib) for Treating Myelofibrosis
June 25, 2024
Ochre Bio and GSK Team Up to Explore the Drivers of Liver Disease
June 13, 2024
GSK’s Arexvy Gains the US FDA’s Approval for Expanded Age Indication to Prevent RSV Lower Respiratory Tract Disease
June 10, 2024
GSK Acquires Elsie Biotechnologies to Advance Oligonucleotide Platform and Pipeline Therapies
June 7, 2024
GSK Highlights P-III (DREAMM-8) Study Data of Blenrep Plus Pomalidomide and Dexamethasone for R/R Multiple Myeloma at ASCO 2024
June 3, 2024
Load more...
Back to Home